TaiMed Biologics Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr '26 Apr 16, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	14,562	16,720	23,485	20,746	17,843	17,813
Market Cap Growth	-44.34%	-28.80%	13.20%	16.27%	0.17%	-16.02%
Enterprise Value	13,287	15,456	21,842	20,859	17,860	17,487
Last Close Price	53.30	61.20	86.00	80.83	69.69	69.59
Forward PE	-	-	-	282.76	-	-
PS Ratio	23.82	27.35	38.49	42.19	31.69	43.09
PB Ratio	3.77	4.33	5.84	8.09	6.57	6.06
P/TBV Ratio	4.26	4.89	6.74	10.69	8.96	8.40
P/FCF Ratio	86.43	99.24	-	-	-	-
P/OCF Ratio	76.18	87.47	-	-	-	-
EV/Sales Ratio	21.73	25.28	35.80	42.42	31.72	42.30
EV/FCF Ratio	78.86	91.74	-	-	-	-
Debt / Equity Ratio	0.13	0.13	0.13	0.29	0.28	0.19
Debt / FCF Ratio	2.93	2.93	-	-	-	-
Net Debt / Equity Ratio	-0.33	-0.33	-0.28	0.04	0.05	-0.13
Net Debt / EBITDA Ratio	27.42	27.42	10.81	-5.89	-2.92	1.16
Net Debt / FCF Ratio	-7.57	-7.57	2.91	-3.29	-0.20	1.77
Asset Turnover	0.13	0.13	0.14	0.12	0.13	0.08
Inventory Turnover	0.24	0.24	0.28	0.20	0.27	0.27
Quick Ratio	7.48	7.48	13.26	2.31	2.32	5.12
Current Ratio	13.11	13.11	25.18	5.96	6.56	10.37
Return on Equity (ROE)	-4.26%	-4.26%	-6.13%	-7.38%	-9.52%	-14.82%
Return on Assets (ROA)	-2.48%	-2.48%	-3.55%	-2.60%	-2.75%	-6.20%
Return on Capital Employed (ROCE)	-4.30%	-4.30%	-5.20%	-4.70%	-5.10%	-11.10%
Earnings Yield	-1.15%	-1.00%	-0.86%	-0.94%	-1.51%	-2.64%
FCF Yield	1.16%	1.01%	-1.65%	-0.15%	-3.41%	-1.24%
Buyback Yield / Dilution	-1.85%	-1.85%	-6.08%	-0.18%	-0.04%	-0.03%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.